Crescent Park Management, L.P. - Jun 2, 2021 Form 4 Insider Report for Genesis Park Acquisition Corp. (RDW)

Role: 10%+ Owner
Signature: Doug Edwards, Chief Financial Officer of Crescent Park Management, L.P.
Stock symbol: RDW
Transactions as of: Jun 2, 2021
Transactions value $: $78,871
Form type: 4
Date filed: 6/4/2021, 05:41 PM
Next filing: Jul 15, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RDW	Class A Ordinary Shares	Purchase	$78.9K	+7.86K	+0.31%	$10.04	2.55M	Jun 2, 2021	See Notes 1 and 2	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RDW	Equity Swap (obligation to buy)	Other		+1			1	Jun 2, 2021	Warrant	4.33K	$1.57	See Notes 1 and 2	F1, F2, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting persons are Crescent Park Management, L.P. ("Crescent Park"), Crescent Park GP, LLC ("Crescent Park GP") and Eli D. Cohen. Crescent Park is the investment adviser of investment funds (the "Funds"), and Crescent Park GP is the general partner of the Funds. Mr. Cohen is the control person of Crescent Park and Crescent Park GP. Crescent Park is filing this report for itself and the other reporting persons. The reporting persons are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934.
F2	The Funds hold the securities reported herein directly for the benefit of their investors. Crescent Park and Crescent Park GP indirectly beneficially own the securities reported herein as the investment adviser and general partner, respectively, of the Funds. Mr. Cohen indirectly beneficially owns the securities reported herein as the control person of Crescent Park and Crescent Park GP. The reporting persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest in them.
F3	On June 2, 2021, the reporting persons entered into an equity swap agreement with a securities broker under which, upon expiration of the two-year term of agreement, either (1) the broker will be required to pay to the reporting persons an amount representing the price of a warrant of the Issuer at the time of expiration, less $1.5696, multiplied by 4,330 warrants, less accrued broker financing charges or (2) the reporting persons will be required to pay to the broker an amount representing $1.5696 less the price of a warrant of the Issuer at the time of expiration, multiplied by 4,330 warrants, plus accrued broker financing charges.
F4	Each warrant entitles the holder to purchase one Class A ordinary share of the Issuer at a price of $11.50 per share, becomes exercisable on the later of 30 days after the completion of the Issuer's initial business combination and November 27, 2021, and expires five years after the completion of the Issuer's initial business combination or earlier upon redemption of the warrants or liquidation of the Issuer.